Approvals/TGA/NASONEX ALLERGY mometasone furoate 50 micrograms/ actuation (as monohydrate) aqueous nasal spray

Approved

STANDARD

NASONEX ALLERGY mometasone furoate 50 micrograms/ actuation (as monohydrate) aqueous nasal spray

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5d714e543c50fc08
Product Name: NASONEX ALLERGY mometasone furoate 50 micrograms/ actuation (as monohydrate) aqueous nasal spray
Artg Id: 215798
Artg Name: NASONEX ALLERGY mometasone furoate 50 micrograms/ actuation (as monohydrate) aqueous nasal spray
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2013-10-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

5d714e543c50fc08

Type

Standard